Description

4-Chloro-n-{[3-([1,3]Oxazolo[4,5-B]Pyridin-2-Yl)Phenyl]Carbamothioyl}Benzamide is a sophisticated heterocyclic organic compound featuring a benzamide core integrated with oxazolopyridine and thiourea pharmacophores. This complex molecular architecture makes it a valuable high-purity intermediate for advanced research and development, particularly in the pharmaceutical sector. It is primarily sought by R&D chemists and process development scientists working on novel active pharmaceutical ingredients (APIs), especially in areas targeting kinase inhibition and other therapeutic pathways.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly for oncology and central nervous system (CNS) targets.
• Biochemical Research: Used as a reference standard or probe molecule in enzymatic and receptor binding assays to study biological pathways.
• Medicinal Chemistry: Serves as a core scaffold for structure-activity relationship (SAR) studies to optimize potency and selectivity of lead compounds.
• Chemical Synthesis: Employed in advanced organic synthesis for constructing complex heterocyclic systems with potential biological activity.
• Academic Research: Utilized in university and institutional labs for fundamental research in organic chemistry and drug discovery methodologies.

Basic Information

Product Name	4-Chloro-n-{[3-([1,3]Oxazolo[4,5-B]Pyridin-2-Yl)Phenyl]Carbamothioyl}Benzamide
CAS No.	425411-42-3
Molecular Formula	C20H13ClN4O2S
Molecular Weight	408.86 g/mol
Synonyms	4-Chloro-N-{[3-(1,3-oxazolo[4,5-b]pyridin-2-yl)phenyl]carbamothioyl}benzamide; 4-Chloro-N-((3-(oxazolo[4,5-b]pyridin-2-yl)phenyl)carbamothioyl)benzamide; Benzamide, 4-chloro-N-[[3-[1,3]oxazolo[4,5-b]pyridin-2-yl]phenyl]carbamothioyl]-; 425411-42-3; UNII-9K9S5N6Z8H; 9K9S5N6Z8H
EINECS	Contact for details

Quality Control

Our 4-Chloro-n-{[3-([1,3]Oxazolo[4,5-B]Pyridin-2-Yl)Phenyl]Carbamothioyl}Benzamide is produced under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and spectroscopic identification (NMR, MS), to ensure it meets the exacting standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The compound may be light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.